Market outlook & challenges
Indeed, the medical devices industry is undergoing significant transformation, driven by a shift towards a continuum-of-care model that emphasizes providing personalized and patient-specific solutions across different settings and stages of life. As the global population ages, there is an increasing demand for innovative technologies tailored to individual patient needs. Advances in areas such as digitalization and robotics are enhancing precision and efficiency in medical devices with increasing complexity, leading to improved patient outcomes and experiences.
Additionally, the pressure to reduce costs is prompting manufacturers to streamline operations and simplify supply chains, while regionalization efforts bolster supply security and responsiveness. At Evonik, we take pride in our global footprint, which allows us to manage our supply chain effectively and support the evolving needs of the medical devices market. We are committed to driving innovations that reflect these trends and enhance the standard of patient-centric care.
How can medical devices support better patient outcomes at different stages of care?
How can manufacturers develop differentiated medical devices tailored to specific clinical needs?
How can medical device manufacturers accelerate innovation while managing increasing complexity?
Your Innovation Hub for Next-Generation Biomaterials to Create a Life Beyond Limits.
A strong partner for innovating life-changing medical devices. For more than 50 years Evonik has served customers worldwide with innovative materials and services for medical devices. With our global team of experts we support you at every stage of your product development. We offer a comprehensive portfolio of standard and customized biomaterials and value adding services that open up new possibilities for patient-specific treatment, empowering our customers to bring their ideas to life.
Tailored materials and services for medical devices
Evonik provides a wide range of biomaterial-based solutions for the medical devices market. Our next-generation biomaterials are designed to meet the evolving demands of this sector, empowering our customers to swiftly bring impactful medical technologies to market. We offer comprehensive system solutions that include customization, advanced processing platforms, extensive application expertise, and robust regulatory support, all aimed at facilitating the development of cutting-edge medical devices. Our commitment to enhancing patient outcomes underscores the positive impact our materials have on people’s lives, reflecting our dedication to advancing the field of medical technology.
Rooted in science, driven by continuous innovation, and relentlessly committed to the United Nations Sustainable Development Goals, we empower our customers to accelerate time-to-market for new medical technologies that create life beyond limits.
Evonik's portfolio of biomaterials for medical devices
| Products | Class of material | Processibiity | Application area |
|---|---|---|---|
| Endexo® | Additive technology | ||
| Epicite® | Biosynthetic cellulose | ||
| POLYMER VS | Addition curing silicones |
| |
| ROHACELL® | Polymethacrylimide (PMI) | ||
| TROGAMID® CARE | Transparent polyamides (PA) | ||
| VESTAKEEP® Care | Polyether ether ketone polymer ( PEEK) |
| |
| VESTAMID® Care ML | Polyamide 12 polymer (PA12) | ||
| VESTAMID® Care ME | Polyamide 12 elastomers (PEBA) | ||
| VESTENAMER® | Trans-polyoctenamer rubber (TOR) | ||
| VESTODUR® | Polybutylene terephthalate (PBT) | ||
| VISIOMER® | Specialty Methacrylate Monomers |
|
| Products | Class of material | Processibiity | Application area |
|---|---|---|---|
| biocellic® | Biosynthetic cellulose | ||
| DEGACRYL® | Polymethyl methacrylate (PMMA) | ||
| DEGAPLAST® | Acrylic based resins | ||
| NANOCRYL® D | Nanosilica concentrates for acrylic resins |
| |
| Polyether ether ketone polymer ( PEEK) |
| ||
| VISIOMER® | Specialty Methacrylate Monomers |
|
Stories
Frequently asked questions (FAQ)
Evonik is a global partner to medical device manufacturers, providing advanced biomaterials that enable safe and high‑performance devices. Beyond materials, we support innovation through application expertise, customization, and global technical support. Our solutions help customers bring next‑generation medical devices to market.
Evonik supports the full medical device lifecycle – from early material selection and concept development to prototyping, scale‑up, and commercial manufacturing. Our teams work closely with customers to ensure materials, processes, and regulatory requirements are aligned throughout development. This integrated approach reduces risk and accelerates time‑to‑market.
Advanced biomaterials are engineered to interact safely and effectively with the human body while meeting strict performance requirements. They are critical for ensuring biocompatibility, durability, and functionality in medical devices. These materials enable innovation in areas such as minimally invasive procedures and patient‑specific treatments.
Evonik offers a broad portfolio including bioresorbable polymers (RESOMER®), high‑performance polymers (VESTAKEEP®), and recombinant collagen‑like materials (VECOLLAN®). These materials cover short‑term, long‑term, and bioresorbable applications across multiple medical fields. Each platform is designed to meet specific clinical and manufacturing requirements.
Material properties directly influence device performance, safety, and interaction with the body. Biomaterials can support healing, reduce complications, and eliminate the need for secondary surgeries. This leads to improved patient experience and more predictable clinical outcomes.
Evonik biomaterials are used in a wide range of devices, including orthopedic implants, cardiovascular devices, dermal fillers, sutures, and tissue engineering solutions. They are suitable for both implantable and non‑implantable applications. This versatility allows manufacturers to address diverse clinical needs.
Yes, customization is a key capability. Evonik works closely with customers to tailor properties such as mechanical performance and degradation rate. This enables device differentiation and optimized performance for specific applications.
Evonik operates under strict quality systems, including ISO 13485, and provides materials that meet global regulatory standards. Our biomaterials are supported by extensive documentation and proven clinical history. This helps customers streamline regulatory submissions.
Yes, Evonik provides comprehensive data packages and supports customers throughout the regulatory process. This reduces complexity and accelerates approvals.
With a global footprint and established production capabilities, Evonik ensures reliable and consistent material supply. Long‑term experience in regulated markets provides additional confidence. This helps customers mitigate supply chain risks.
